Ayr Strategies To Purchase Liberty Health Sciences For $290M, Debuts In New Jersey With Garden State Dispensary Deal

Vertically integrated cannabis company Ayr Strategies (CSE: AYR.A) (OTCQX: AYRWF) said Tuesday it seeks to acquire the Florida-based Liberty Health Sciences (CSE: LHS) (OTCQX: LHSIF) in a $290-million stock-for-stock transaction.

With the deal, Liberty shareholders will obtain roughly 13.1 million new Ayr shares, or 0.03683 Ayr shares for each Liberty share.

In addition, Ayr said it will acquire Liberty's Gainesville-based cultivation campus, which spans 387 acres, over 300,000 square feet of production facilities, 28 operating dispensaries and seven ready-to-open dispensaries, as well …

Full story available on Benzinga.com

More Ayr Strategies To Purchase Liberty Health Sciences For $290M, Debuts In New Jersey With Garden State Dispensary Deal